Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease

Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease

Abstract Background No results of controlled trials are available for any of the few treatments offered to children with interstitial lung diseases (chILD). We evaluated hydroxychloroquine (HCQ) in a phase 2, prospective, multicentre, 1:1-randomized, double-blind, placebo-controlled, parallel-group/...

Full description

Bibliographic Details
Main Authors: Matthias Griese, Matthias Kappler, Florian Stehling, Johannes Schulze, Winfried Baden, Cordula Koerner-Rettberg, Julia Carlens, Freerk Prenzel, Lutz Nährlich, Andreas Thalmeier, Daniela Sebah, Kai Kronfeld, Hans Rock, Christian Ruckes, the HCQ-study group, Martin Wetzke, Elias Seidl, Nicolaus Schwerk
Format: Article
Language:English
Published: BMC 2022-07-01
Series:Orphanet Journal of Rare Diseases
Subjects:
chILD
Interstitial lung diseases
Hydroxychloroquine
Randomized-controlled trial
Online Access:https://doi.org/10.1186/s13023-022-02399-2

Internet

https://doi.org/10.1186/s13023-022-02399-2

Similar Items